[16] showed a trend towards a nonsignificant higher risk of recurrent thrombosis during treatment with DOACs compared with VKA use in APS patients with triple positivity.
← all excerpts
Comparing the efficacy and safety of direct oral anticoagulants versus Vitamin K antagonists in patients with antiphospholipid syndrome: a systematic review and meta-analysis.
1
—
—